CLAIM #48440 · Pfizer Inc (PFE) · 2024Q3 earnings call · Oct 29, 2024 · due Dec 31, 2024
“We expect adjusted diluted earnings per share of $2.75 to $2.95, primarily reflecting the top line increase and absorbing the Oxbryta impact.”
David Denton · CFO
PENDING
graded after results covering Dec 31, 2024 are reported
Verify independently
SEC filings for PFE ↗ · Claim quote is verbatim from the 2024Q3 earnings call.